neuroscienceCME Clinical Compass(TM)
Subscribe to Clinical Compass™ Volume 6, Issue 20 - Septemaber 20, 2011

Compass Points

Adjunctive Pharmacotherapy Strategies for Treatment of Major Depressive Disorder


Based on findings from the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) study, about two-thirds of patients do not achieve remission after initial treatment with a first-line antidepressant(1) and only about half experience response. As such is the case, clinicians must become skilled at use of innovative strategies designed to improve...

Read more (Earn up to 0.5 AMA PRA Category 1 Credit(s)™)
Back to top


pre-Compass Questions™

Your responses to this issue's Compass Questions™ will be added to an ongoing needs assessment for educational programming in this important area. Responses to this issue's questions will be reported in an upcoming issue.

Question #1
Data suggest that about two-thirds of patients with major depressive disorder do not achieve remission after initial treatment with a first-line antidepressant. Is this consistent with what you note in your clinical experience?
Yes.
No, I note a higher success rate.
No, I note a lower success rate.
N/A or unsure.

Question #2
Reflect upon your use of adjunctive therapy to antidepressants in patients with depression who did not respond to initial antidepressant monotherapy. How often to you currently employ lithium as the first add-on therapy?
0% – 25% of the time
26% – 50% of the time
51% – 75% of the time
Over 75% of the time
N/A – This is not my clinical role.


Question #3
Reflect upon your use of adjunctive therapy to antidepressants in patients with depression who did not respond to initial antidepressant monotherapy. How often do you currently employ thyroid hormone as the first add-on therapy?
0% – 25% of the time
26% – 50% of the time
51% – 75% of the time
Over 75% of the time
N/A – This is not my clinical role.


Question #4
Reflect upon your use of adjunctive therapy to antidepressants in patients with depression who did not respond to initial antidepressant monotherapy. How often to you currently employ olanzapine, aripiprazole, or quetiapine as the first add-on therapy?
0% – 25% of the time
26% – 50% of the time
51% – 75% of the time
Over 75% of the time
N/A – This is not my clinical role.


Back to top


Responses from Last Compass Questions™

In the 09.06.11 issue of Clinical Compass™, we asked seven questions.

Question #1 was "Before reading this article, rate your knowledge about the use and value of sport psychology." and the neuroscienceCME learning community responded:
0.0% - Extremely knowledgeable
4.5% - very knowledgeable
18.2% - Moderately knowledgeable
33.3% - Somewhat knowledgeable
43.9% - Not at all knowledgeable
0.0% - N/A - This is not my role

Question #2 was "Before reading this article, state how often you have you considered a referral to a sport psychologist in your practice." and the neuroscienceCME learning community responded:
1.5% - Always
1.5% - Often
13.6% - Sometimes
28.8% - Rarely
53.0% - Never
1.5% - N/A - This is not my role

Question #3 was "Has reading this article improved your knowledge of sport psychology?" and the neuroscienceCME learning community responded:
10.3% - Extremely
48.3% - Very much
34.5% - Somewhat
6.9% - Slightly
0.0% - Not at all
0.0% - N/A - This is not my role

Question #4 was "Now that you have read this article, will you consider discussing sports behavior more often with patients in your practice?" and the neuroscienceCME learning community responded:
10.3% - Always
17.2% - Often
34.5% - Sometimes
13.8% - Rarely
0.0% - Never
24.1% - N/A - This is not my role

Question #5 was "Rate your interest in more educational activities on sports psychology." and the neuroscienceCME learning community responded:
24.1% - Extremely interested
41.4% - Very interested
24.1% - Moderately interested
10.3% - Somewhat interested
0.0% - Not at all interested

Back to top


neuroscienceCME Live and On Demand

Setting the Bar High in Major Depressive Disorder: Helping Patients Reach and Retain Remission

Premiere Date: Wednesday, October 26, 2011
Live Broadcast: 12:00–1:00 p.m. ET
"After the Show" live Q&A webcast: 1:02 - 1:30 p.m. ET
Taped Re-Air: 4:00–5:00 p.m. ET

View activity details
Add to calendar

REGISTER NOW!

Back to top

In This Issue

Adjunctive Pharmacotherapy Strategies for Treatment of Major Depressive Disorder

pre-Compass Questions™

Responses from Last Compass Questions™

Setting the Bar High in Major Depressive Disorder: Helping Patients Reach and Retain Remission

Live CME/CE

October 5, 2011
neuroscienceCME
Live and On Demand

Connecting the Dots in Antipsychotic Maintenance Therapy

FACULTY

Henry A. Nasrallah, MD
Henry A. Nasrallah, MD
(Moderator)


Leslie Citrome, MD, MPH
Leslie Citrome, MD, MPH

Diana O. Perkins, MD, MPH
Diana O. Perkins, MD, MPH

View activity details
Add to calendar
Register now

October 26, 2011
neuroscienceCME
Live and On Demand

Setting the Bar High in Major Depressive Disorder: Helping Patients Reach and Retain Remission

FACULTY

Henry A. Nasrallah, MD
Michael E. Thase, MD
(Moderator)


Leslie Citrome, MD, MPH
Linda L. Carpenter, MD

Diana O. Perkins, MD, MPH
Madhukar H. Trivedi, MD


View activity details
Add to calendar
Register now

November 17, 2011
neuroscienceCME
Chart Review

Chart Review and Exploration of Achieving Remission in Major Depressive Disorder

FACULTY

Henry A. Nasrallah, MD
Rakesh Jain, MD, MPH
(Moderator)


Leslie Citrome, MD, MPH
Madhukar H. Trivedi, MD

View activity details
Add to calendar
Register now

December 1, 2011
neuroscienceCME
Chart Review

Chart Review and Exploration of Sustaining Remission in Major Depressive Disorder

FACULTY

Henry A. Nasrallah, MD
Rakesh Jain, MD, MPH
(Moderator)


Leslie Citrome, MD, MPH
Michael E. Thase, MD

View activity details
Add to calendar
Register now

Self-Study CME/CE

Sports, Psychology, and Superstition

Compass Points

FACULTY
Robert Kennedy

View activity details

Pneumococcal Disease in High-Risk Patients: Strategies for Appropriate Selection of Patients for Vaccination

CMEO Webcasts

FACULTY
Keith P. Klugman, MD, PhD Michael S. Niederman, MD, FACP, FCCP, FCCM (Moderator)

View activity details

The Nurse's Pivotal Role in Identifying and Managing Symptoms of Multiple Sclerosis

neuroscienceCME Webcast

FACULTY
Kathleen Costello, MS, ANP-BC, MSCN
Patricia M. Kennedy, RN, CNP, MSCN

View activity details

Advances in the Treatment of Schizophrenia: New Approaches

neuroscienceCME Webcast

FACULTY
W. Wolfgang Fleischhacker, MD
Donald C. Goff, MD Phillip D. Harvey, PhD

View activity details

Follow CME Outfitters on:
Follow CME Outfitters on Facebook Facebook  
Follow CME Outfitters on LinkedIn LinkedIn  
Follow CME Outfitters on Twitter Twitter  

CONTACT US
CME Outfitters, LLC
1395 Piccard Drive, Suite 370
Rockville, MD 20850
877.CME.PROS (877.263.7767)
webmaster@cmeoutfitters.com

©2011 CME Outfitters, LLC